{"lastClose": 6.869999885559082, "len": 1091, "date": "2023-02-10", "alpha_1": -0.12959755114558869, "beta_1": 1.658131172683235, "drawup_1": 1.5486725887776869, "natr_1": 12.92062407479994, "sup_1": -0.3915575343488185, "res_1": 0.43668125311789263, "bullPattern_1": [], "bearPattern_1": ["BELTHOLD", "LONGLINE"], "rsi_1": 58.21287816289986, "adx_1": 43.3720443462227, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.21208237147139222, "stratHoldAlpha_1": 250.85380294109203, "stratHoldDrawdown_1": -0.6316359900004376, "alpha_3mo": -0.7918981721389298, "beta_3mo": 2.04788386144263, "drawup_3mo": 0.4608541290620036, "natr_3mo": 12.92062407479994, "sup_3mo": -0.14022316534644547, "res_3mo": 0.04415331696122988, "bullPattern_3mo": [], "bearPattern_3mo": ["SPINNINGTOP"], "rsi_3mo": 50.13850075230655, "adx_3mo": 36.033429093719015, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.86435134506925, "stratHoldAlpha_3mo": 249.82249886957283, "stratHoldDrawdown_3mo": -0.43386692434589313, "IPO Year": 2018.0, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Country": "United States", "Name": "Allogene Therapeutics Inc.", "Sector": "Health Care", "Market Cap": 991444809, "alpha%_1": 0.4563951102247546, "beta%_1": 0.9058467665565284, "drawup%_1": 0.9975489897109144, "natr%_1": 0.9999274664815128, "drawdown%_1": 0.07377894831178151, "stratHoldSharpe%_1": 0.3251858531329198, "stratHoldAlpha%_1": 0.2434577183646358, "stratHoldDrawdown%_1": 0.06229310530750385, "alpha%_3mo": 0.0646781920268744, "beta%_3mo": 0.9677070749861827, "drawup%_3mo": 0.8876838573439765, "natr%_3mo": 0.9998920059828587, "drawdown%_3mo": 0.00011765250892068496, "stratHoldSharpe%_3mo": 0.04985348920881309, "stratHoldAlpha%_3mo": 0.002517292542521326, "stratHoldDrawdown%_3mo": 0.00011295344577592179}